macular degeneration
Novartis’ Beovu approved in Europe after outclassing Eylea in wet age-related macular degeneration
February 18, 2020Manufacturing and Production, Sales and Marketing Beovu, Eylea, Novartis, Regeneron, macular degeneration, pharma
The European Commission (EC) has chosen to approve Novartis’ Beovu (brolucizumab) injection, it has emerged, as a treatment for wet …
FDA launches lawsuits against stem cell clinics after patients rendered blind
May 10, 2018Medical Communications, Sales and Marketing FDA, Stem cells, US, macular degeneration, pharma
At the request of the FDA, The US Department of Justice has launched legal action seeking to shut down stem …
Telescope implant for macular degeneration approved
October 15, 2014Medical Communications, Sales and Marketing FDA, VisionCare Ophthalmic Technologies, macular degeneration, telescope implant
Medical device development firm VisionCare Ophthalmic Technologies has had its implantable miniature telescope for age-related macular degeneration disease approved by …
Latest content
Boyds expands Regulatory Affairs team to support growing demand
October 16, 2026
Sterling doubles ADC manufacturing capacity at Welsh facility
October 16, 2026
Femtosecond laser cuts lung tumour margin assessment time
October 15, 2026
Blood sensor detects Parkinson’s-associated proteins in 40 minutes
October 15, 2026
